tiprankstipranks
Advertisement
Advertisement

NBIX Stock Latest News

Neurocrine price target raised to $220 from $192 at Oppenheimer
The FlyNeurocrine price target raised to $220 from $192 at Oppenheimer
8h ago
NBIX
SLNO
Midday Fly By: Neurocrine to acquire Soleno, Oracle hires new CFO
PremiumThe Fly
Midday Fly By: Neurocrine to acquire Soleno, Oracle hires new CFO
11h ago
WW
AMC
Neurocrine’s Soleno Acquisition: Accretive Rare-Disease Expansion Supporting Long-Term Growth and Buy Rating
PremiumRatings
Neurocrine’s Soleno Acquisition: Accretive Rare-Disease Expansion Supporting Long-Term Growth and Buy Rating
11h ago
NBIX
Morning Movers: Soleno pops, Neurocrine dips after acquisition agreement
PremiumThe Fly
Morning Movers: Soleno pops, Neurocrine dips after acquisition agreement
13h ago
DOW
LGN
Balanced View on Neurocrine Biosciences: Favorable Soleno Acquisition Prospects Offset by Long-Term Ingrezza and Orphan Market Execution Risks
PremiumRatings
Balanced View on Neurocrine Biosciences: Favorable Soleno Acquisition Prospects Offset by Long-Term Ingrezza and Orphan Market Execution Risks
13h ago
NBIX
Neurocrine to Acquire Soleno, Expanding Rare Disease Portfolio
PremiumCompany AnnouncementsNeurocrine to Acquire Soleno, Expanding Rare Disease Portfolio
15h ago
8K
NBIX
Neurocrine to acquire Soleno Therapeutics for $53.00 per share in cash
Premium
The Fly
Neurocrine to acquire Soleno Therapeutics for $53.00 per share in cash
15h ago
NBIX
SLNO
Neurocrine to acquire Soleno Therapeutics for $53.00 per share in cash, or $2.9B
Premium
The Fly
Neurocrine to acquire Soleno Therapeutics for $53.00 per share in cash, or $2.9B
15h ago
NBIX
SLNO
M&A News: Soleno Therapeutics Stock (SLNO) Surges 28% as Neurocrine Biosciences Lines up $2.5B Deal
PremiumMarket News
M&A News: Soleno Therapeutics Stock (SLNO) Surges 28% as Neurocrine Biosciences Lines up $2.5B Deal
17h ago
NBIX
SLNO
Neurocrine appoints Andrew Ratz as Chief Technical Operations Officer
PremiumThe Fly
Neurocrine appoints Andrew Ratz as Chief Technical Operations Officer
20d ago
NBIX
Neurocrine price target raised to $177 from $176 at JPMorgan
PremiumThe Fly
Neurocrine price target raised to $177 from $176 at JPMorgan
26d ago
NBIX
Neurocrine initiated with an Outperform at Wolfe Research
PremiumThe Fly
Neurocrine initiated with an Outperform at Wolfe Research
1M ago
NBIX
Neurocrine price target lowered to $140 from $169 at Truist
PremiumThe FlyNeurocrine price target lowered to $140 from $169 at Truist
2M ago
NBIX
Neurocrine post-earnings selloff overdone, says JPMorgan
Premium
The Fly
Neurocrine post-earnings selloff overdone, says JPMorgan
2M ago
NBIX
Neurocrine Biosciences Earnings Call Highlights Growth Momentum
Premium
Company Announcements
Neurocrine Biosciences Earnings Call Highlights Growth Momentum
2M ago
NBIX
Neurocrine price target lowered to $177 from $180 at RBC Capital
PremiumThe Fly
Neurocrine price target lowered to $177 from $180 at RBC Capital
2M ago
NBIX
Neurocrine price target lowered to $185 from $187 at Needham
PremiumThe Fly
Neurocrine price target lowered to $185 from $187 at Needham
2M ago
NBIX
Neurocrine price target lowered to $190 from $195 at BofA
PremiumThe Fly
Neurocrine price target lowered to $190 from $195 at BofA
2M ago
NBIX
Neurocrine price target raised to $151 from $149 at Wedbush
PremiumThe Fly
Neurocrine price target raised to $151 from $149 at Wedbush
2M ago
NBIX
Neurocrine price target lowered to $173 from $175 at Morgan Stanley
PremiumThe FlyNeurocrine price target lowered to $173 from $175 at Morgan Stanley
2M ago
NBIX
Reaffirming Buy: Solid Core Franchise Execution and Underappreciated Pipeline Upside Support Mid-$150s Valuation
Premium
Ratings
Reaffirming Buy: Solid Core Franchise Execution and Underappreciated Pipeline Upside Support Mid-$150s Valuation
2M ago
NBIX
Neurocrine Biosciences: Durable Ingrezza Franchise and Emerging Crenessity Uptake Support Buy Rating and $190 Price Target
Premium
Ratings
Neurocrine Biosciences: Durable Ingrezza Franchise and Emerging Crenessity Uptake Support Buy Rating and $190 Price Target
2M ago
NBIX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >